Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Nutraceuticals may improve skin health and protect against aging, but more research is needed on their optimal use and possible health risks.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document concludes that molluscum contagiosum is a common, benign skin infection in children, often healing without scarring.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The EDAR gene greatly affects hair thickness in Asian populations.

MDP hydrogel heals wounds faster and better than other treatments in diabetic mice.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Advanced hydrogel systems with therapeutic agents could greatly improve acute and chronic wound treatment.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Some systemic treatments work for nail psoriasis but can have serious side effects.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Notch-related genes play a key role in the development and cycling of hair follicles.

Melatonin affects mouse skin and may regulate skin functions.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.